GRIFOLS | GRF - Interest Expense On Debt


GRIFOLS reported EUR141.43M in Interest Expense on Debt for its fiscal quarter ending in June of 2025.





Interest Expense On Debt Change Date
Alcon AG USD 53M 1000K Jun/2026
Amadeus IT EUR 25.3M 5M Sep/2026
Amarin USD 3K 5K Dec/2024
argenx SE USD 1000K 0 Sep/2026
AstraZeneca USD 371M 31M Sep/2026
Bayer EUR 675M 87M Dec/2025
Demant DKK 424M 26M Jun/2026
Ence Energia y Celulosa EUR 16.2M 7.1M Dec/2025
Essilor EUR 188M 20M Jun/2026
Fresenius EUR 81M 5M Sep/2025
Fresenius Medical Care EUR 97.5M 14.5M Sep/2026
Genmab DKK 139M 129M Jun/2026
GlaxoSmithKline GBP 219M 98M Sep/2026
GRIFOLS EUR 141.43M 61.28M Jun/2025
Hikma Pharmaceutical USD 67M 47M Dec/2025
Inditex EUR 35M 19M Jun/2026
Lakefront Biotherapeutics EUR 1.72M 940K Sep/2025
Merck EUR 119M 18M Sep/2026
Novartis USD 468M 6M Sep/2026
Philips EUR 84M 1000K Sep/2026
Roche Holding CHF 304M 7.5M Jun/2025
Sanofi EUR 222M 65M Sep/2026
Smith & Nephew USD 69M 1000K Dec/2025
UCB EUR 49M 29M Dec/2025
Viscofan EUR 3.84M 1.2M Sep/2026